Historical aspects of multiple sclerosis;Aspectos históricos de la esclerosis múltiple

Revista de Neurologia

Volumn 34, Issue 4, 2002, Pages 378-383

  Moreira, Marcos Aurélio ^a   Tilbery, C P ^a   Lana Peixoto, M A ^a   Mendes, M ^a   Kaimen Maciel, D R ^a   Callegaro, D ^a  

^a NONE   (Brazil)

Author keywords

History; Multiple sclerosis

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; CORTICOSTEROID; CORTICOTROPIN; GLATIRAMER; INTERFERON BETA SERINE;

DISABILITY; GENETIC SUSCEPTIBILITY; HUMAN; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; RATING SCALE; RELAPSE; REVIEW; ARTICLE; DIFFERENTIAL DIAGNOSIS; HISTORY; NEUROLOGY;

DIAGNOSIS, DIFFERENTIAL; DISABILITY EVALUATION; HISTORY, 15TH CENTURY; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MULTIPLE SCLEROSIS; NEUROLOGY;

EID: 0037117056     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3404.2001313     Document Type: Review

References (60)

1. The story of multiple sclerosis
2. La sclérose en plaques. De Charcot et Vulpian a nos jours
3. Comptes rendus des seances et memoires lus a la Société de Biologie
4. Histologie de la sclerose en plaque
5. Note sur la sclérose en plaques de la moelle épinière
6. The epidemiology of multiple sclerosis: A general overview
7. th century?
8. La sclerose en plaques et maladies infectieuses
9. Results of treatment of multiple sclerosis with dicoumarin
10. The experimental transmission of disseminated sclerosis to rabbits
11. Acute plaques in multiple sclerosis, their pathogenic significance and the role of spirochetes as etiological factors
12. Aetiology of disseminated sclerosis
13. A specific vaccine treatment in disseminated sclerosis
14. The aetiology of disseminated sclerosis: Some criticisms of recent work especially with regard to the 'Spherula insularis'
15. The virology of demyelinating diseases
16. Significance of reactive Lyme serology in multiple sclerosis
17. Multiple sclerosis and positive Lyme serology
18. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
19. Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?
20. Epstein-Barr virus and multiple sclerosis
21. Association between clinical disease activity and Epstein-Barr virus reactivation in MS
22. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys
23. Rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of brain tissue with adjuvants
24. A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of one hundred cases of multiple sclerosis an in other diseases
25. Multiple sclerosis: From the standpoint of geographic distribution and race
26. Multiple sclerosis in Israel
27. Annual incidence, prevalence, and mortality of multiple sclerosis in white south-african-born and white immigrants to South-Africa
28. Epidemiological contributions to multiple sclerosis: An overview
29. Genetic epidemiology of multiple sclerosis: A survey
30. Multiple sclerosis. Observations and reflexions - A personal memoir
31. Vikings voyages: The origin of multiple sclerosis? An essay in medical history
32. A new scale for evaluating disability in multiple sclerosis
33. Isoniazid in treatment of multiple sclerosis. Report on Veterans Administration cooperative study
34. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
35. Prevalence and familial incidence of disseminated sclerosis (a report of the Northern Ireland Hospitals Authority on the results of a three-year survey): Prevalence of disseminated sclerosis in northern Ireland
36. Problems of experimental trials of therapy in multiple sclerosis
37. Criteria for the clinical diagnosis in MS
38. Diagnosis and classification of multiple sclerosis
39. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
40. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis
41. CSF in multiple sclerosis
42. Electroencephalographic and pneumoencephalographic studies of multiple sclerosis
43. The contracting cord sign of multiple sclerosis
44. Computerized axial tomography in multiple sclerosis
45. Nuclear magnetic resonance imaging of the brain in multiple sclerosis
46. Delayed visual evoked response in optic neuritis
47. Central remyelination restores secure conduction
48. Multiple sclerosis: Treatment of acute exacerbations with corticotropin (ACTH)
49. Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH versus placebo: Final report
50. Possible beneficial effect of high dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis
51. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: Clinical-immunologic correlations
52. Interferon beta 1-b is effective in relapsing-remitting multiple sclerosis
53. Intramuscular interferon beta 1-a for disease progression in relapsing multiple sclerosis
54. Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
55. Randomized double-blind placebo-controlled study of interferon beta 1-a in relapsing-remitting multiple sclerosis